Related Experiment Videos
Lysyl oxidase as a potential therapeutic target
Cristina Rodríguez1, Antonio Rodríguez-Sinovas, José Martínez-González
1Centro de Investigacion Cardiovascular (CSIC-ICCC), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. crodriguezs@csic-iccc.org
Drug News & Perspectives
|June 19, 2008
Summary
Lysyl oxidase (LOX) is crucial for connective tissue strength. Its dysregulation is implicated in various diseases, highlighting LOX as a potential therapeutic target for fibrotic, cancerous, and cardiovascular conditions.
Area of Science:
- Biochemistry and Molecular Biology
- Pathophysiology
- Extracellular Matrix Biology
Background:
- Lysyl oxidase (LOX) is a copper-dependent enzyme essential for cross-linking collagen and elastin.
- This cross-linking is critical for the mechanical integrity of the extracellular matrix (ECM) and connective tissues.
- ECM remodeling is a hallmark of numerous pathological conditions.
Purpose of the Study:
- To review clinical and experimental evidence linking LOX to various diseases.
- To explore the role of LOX dysregulation in the pathophysiology of connective tissue disorders.
- To identify LOX as a potential therapeutic target for multiple pathologies.
Main Methods:
- Review of existing clinical studies.
- Analysis of experimental research findings.
- Synthesis of evidence on LOX function in disease.
Main Results:
- LOX activity is integral to ECM structure and tissue mechanics.
- Dysregulation of LOX is associated with fibrotic processes.
- LOX plays a role in tumor progression, metastasis, neurodegeneration, and cardiovascular diseases.
Conclusions:
- LOX is a key factor in the pathophysiology of diverse diseases.
- Targeting LOX presents a promising therapeutic strategy for connective tissue pathologies.
- Further research into LOX modulation could lead to novel treatments.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
02:44Oxidation of Alkenes: Syn Dihydroxylation with Osmium Tetraoxide
Alkenes are converted to 1,2-diols or glycols through a process called dihydroxylation. It involves the addition of two hydroxyl groups across the double bond with two different stereochemical approaches, namely anti and syn. Dihydroxylation using osmium tetroxide progresses with syn stereochemistry.
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:24Peroxisomes
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...